Study of FOXO3a and the development of tamoxifen resistance in breast cancer

被引：0
|
作者：
Chen, Jie
Wu, Lai-han
Ip, Ying-Chi
Chan, Kelvin Y. K.
Lam, Eric W-F
Khoo, Ui-soon
机构：
[1] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, Canc Res UK Labs, London, England
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4724
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FOXO3a in cancer drug resistance
    Liu, Ying
    Wang, Yu
    Li, Xiaoge
    Jia, Yi
    Wang, Jianxun
    Ao, Xiang
    CANCER LETTERS, 2022, 540
  • [2] FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity
    Fiorillo, Marco
    Ricci, Elena
    Fava, Mariarosa
    Longobucco, Camilla
    Sotgia, Federica
    Rizza, Pietro
    Lanzino, Marilena
    Bonofiglio, Daniela
    Conforti, Francesca Luisa
    Catalano, Stefania
    Barone, Ines
    Morelli, Catia
    Aquila, Saveria
    Lisanti, Michael P.
    Sisci, Diego
    CELLS, 2023, 12 (24)
  • [3] FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer
    Pellegrino, Michele
    Rizza, Pietro
    Dona, Ada
    Nigro, Alessandra
    Ricci, Elena
    Fiorillo, Marco
    Perrotta, Ida
    Lanzino, Marilena
    Giordano, Cinzia
    Bonofiglio, Daniela
    Bruno, Rosalinda
    Sotgia, Federica
    Lisanti, Michael P.
    Sisci, Diego
    Morelli, Catia
    CANCERS, 2019, 11 (12)
  • [4] FoxO3a Reduces Tamoxifen Resistant Breast Cancer Aggressiveness by Inducing Integrin a5 Expression
    Ricci, Elena
    Fava, Mariarosa
    Rizza, Pietro
    Pellegrino, Michele
    Sisci, Diego
    Morelli, Catia
    FASEB JOURNAL, 2021, 35
  • [5] FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression
    Ricci, Elena
    Fava, Mariarosa
    Rizza, Pietro
    Pellegrino, Michele
    Bonofiglio, Daniela
    Casaburi, Ivan
    Lanzino, Marilena
    Giordano, Cinzia
    Bruno, Rosalinda
    Sirianni, Rosa
    Barone, Ines
    Sisci, Diego
    Morelli, Catia
    CANCERS, 2022, 14 (01)
  • [6] FOXO3a Reverses the Cisplatin Resistance in Ovarian Cancer
    Lu, Mudan
    Chen, Xuan
    Xiao, Jianping
    Xiang, Jingying
    Yang, Lan
    Chen, Daozhen
    ARCHIVES OF MEDICAL RESEARCH, 2018, 49 (02) : 84 - 88
  • [7] Foxo3a Expression Is a Prognostic Marker in Breast Cancer
    Jiang, Ying
    Zou, Lin
    Lu, Wei-Qi
    Zhang, Yong
    Shen, Ai-Guo
    PLOS ONE, 2013, 8 (08):
  • [8] Activation of FOXO3a reverses 5-Fluorouracil resistance in human breast cancer cells
    Song, Ying
    Lu, Minying
    Qiu, Huisi
    Yin, Jiang
    Luo, Kai
    Zhang, Zhijie
    Jia, Xiaoting
    Zheng, Guopei
    Liu, Hao
    He, Zhimin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2018, 105 (01) : 57 - 62
  • [9] Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review
    Taylor, Simon
    Lam, Matthew
    Pararasa, Chathyan
    Brown, James E. P.
    Carmichael, Amtul R.
    Griffiths, Helen R.
    CANCER CELL INTERNATIONAL, 2015, 15
  • [10] Role and regulation of FOXO3a: new insights into breast cancer therapy
    Mei, Wenqiu
    Mei, Bingyin
    Chang, Jing
    Liu, Yifei
    Zhou, Yanhong
    Zhu, Ni
    Hu, Meichun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345